NeuroOne Medical Technologies Corporation NMTC 深 滬
交易中 10-06 11:18:09 美东时间
1.01
+0.080
+8.60%
華盛通- 最 高1.015
- 今 開0.985
- 成交量 44.77万股
- 最 低 0.9652
- 昨 收 0.93
- 總市值 5049.95万
- 52周最高 1.39
- 市盈率 靜 --
- 換手率 0.90%
- 52周最低 0.3954
- 委 比 -78.95%
- 總股本 4999.95万
- 歷史最高 7.97
- 量 比 6.86
- 振 幅 5.35%
- 歷史最低 0.3954
- 每 手 1
- 風險率 0.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sidoti Events, LLC's Virtual September Small-Cap Conference
NEW YORK, NY / ACCESS Newswire / September 16, 2025 / Sidoti Events, LLC, an af...
09-16 23:20
美股大行评级 | 潜在涨幅577.08%！Veritone获D. Boral Capital升目标价至26美元，维持"买入"评级
今日重点评级关注：D. Boral Capital：维持Veritone"买入"评级，目标价从6美元升至26美元；Guggenheim：维持Dianthus Therapeutics"买入"评级，目标价从92美元升至100美元
09-10 18:01
Maxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3
Maxim Group analyst Anthony Vendetti initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $3.
09-09 22:23
NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025
NeuroOne Medical Technologies Corporation will participate in the Sidoti & Co. Virtual Small-Cap Conference on September 17-18, 2025. CEO Dave Rosa and CFO Ron McClurg will present on September 17 at 12:15pm ET and host investor meetings. The company reported a 105% revenue increase to $1.7 million in Q3 2025 and a 53.9% gross margin, along with FDA clearance for its OneRF® system. NeuroOne aims to raise investor awareness and discuss growth oppo...
09-08 20:05
NeuroOne Gains FDA Clearance for Nerve Ablation System
NeuroOne Medical Technologies ( ($NMTC) ) has provided an announcement. On Augu...
08-18 20:58
NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
NeuroOne Medical Technologies Corporation received FDA clearance for its OneRF® Trigeminal Nerve Ablation System, enabling minimally invasive treatment of trigeminal neuralgia, a chronic pain condition affecting around 150,000 people annually. The system uses targeted radiofrequency energy to ablate trigeminal nerve fibers, offering a safer, more precise alternative to traditional pharmaceutical and surgical treatments. NeuroOne plans a limited c...
08-18 12:30
NeuroOne Updates Prospectus for $6.75 Million Offering
NeuroOne Medical Technologies ( ($NMTC) ) has provided an update. On December 2...
08-16 04:58
NeuroOne Medical Technologies shares are trading lower after the company reported a Q2 sales miss.
NeuroOne Medical Technologies shares are trading lower after the company report...
08-15 01:30
NeuroOne Medical Tech Affirms FY2025 Sales Guidance of $8.00M-$10.00M vs $8.71M Est
NeuroOne Medical Tech (NASDAQ:NMTC) affirms FY2025 sales outlook from $8.00 million-$10.00 million to $8.00 million-$10.00 million vs $8.71 million estimate.
08-14 19:36
